OSE TherapeuticsOSE ImmunotherapeuticsStrengthening developmentAppointmentsDr Sonya Montgomery joined OSE Immunotherapeutics SA, based in Nantes, France, as Chief Development Officer. Read more 18 March 2025 https://european-biotechnology.com/wp-content/uploads/2025/03/eb.com_Sonya_Montgomery.jpg 472 420 Maren Kühr /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Maren Kühr2025-03-18 09:22:152025-03-25 09:23:58Strengthening development
OSE Therapeutics
